As new modelling paints a grim picture of where Canada s COVID-19 pandemic is headed, the country s already sluggish efforts to get vaccines out to Canadians suffered a jolt today. Procurement Minister Anita Anand said production issues in Europe will temporarily reduce Pfizer s-BioNTech s ability to deliver vaccines to Canada. (Pfizer-BioNTech also announced it was reducing deliveries…
Canada has approved two vaccines and is currently scheduled to receive four million doses from Pfizer-BioNTech and another two million from Moderna before the end of March. That is the same delivery plan that has existed since November.